CXCR4 Antagonists Market, Global Outlook and Forecast 2023-2028

Report ID: 1372576 | Published Date: Jan 2025 | No. of Page: 63 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 CXCR4 Antagonists Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global CXCR4 Antagonists Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global CXCR4 Antagonists Overall Market Size
    2.1 Global CXCR4 Antagonists Market Size: 2021 VS 2028
    2.2 Global CXCR4 Antagonists Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top CXCR4 Antagonists Players in Global Market
    3.2 Top Global CXCR4 Antagonists Companies Ranked by Revenue
    3.3 Global CXCR4 Antagonists Revenue by Companies
    3.4 Top 3 and Top 5 CXCR4 Antagonists Companies in Global Market, by Revenue in 2021
    3.5 Global Companies CXCR4 Antagonists Product Type
    3.6 Tier 1, Tier 2 and Tier 3 CXCR4 Antagonists Players in Global Market
        3.6.1 List of Global Tier 1 CXCR4 Antagonists Companies
        3.6.2 List of Global Tier 2 and Tier 3 CXCR4 Antagonists Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global CXCR4 Antagonists Market Size Markets, 2021 & 2028
        4.1.2 BL-8040
        4.1.3 GMI-1359
        4.1.4 Plerixafor (AMD3100)
        4.1.5 Balixafortide (POL6326)
        4.1.6 USL311
        4.1.7 Others
    4.2 By Type - Global CXCR4 Antagonists Revenue & Forecasts
        4.2.1 By Type - Global CXCR4 Antagonists Revenue, 2017-2022
        4.2.2 By Type - Global CXCR4 Antagonists Revenue, 2023-2028
        4.2.3 By Type - Global CXCR4 Antagonists Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global CXCR4 Antagonists Market Size, 2021 & 2028
        5.1.2 Cancer
        5.1.3 HIV
        5.1.4 Chronic Inflammatory Diseases
    5.2 By Application - Global CXCR4 Antagonists Revenue & Forecasts
        5.2.1 By Application - Global CXCR4 Antagonists Revenue, 2017-2022
        5.2.2 By Application - Global CXCR4 Antagonists Revenue, 2023-2028
        5.2.3 By Application - Global CXCR4 Antagonists Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global CXCR4 Antagonists Market Size, 2021 & 2028
    6.2 By Region - Global CXCR4 Antagonists Revenue & Forecasts
        6.2.1 By Region - Global CXCR4 Antagonists Revenue, 2017-2022
        6.2.2 By Region - Global CXCR4 Antagonists Revenue, 2023-2028
        6.2.3 By Region - Global CXCR4 Antagonists Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America CXCR4 Antagonists Revenue, 2017-2028
        6.3.2 US CXCR4 Antagonists Market Size, 2017-2028
        6.3.3 Canada CXCR4 Antagonists Market Size, 2017-2028
        6.3.4 Mexico CXCR4 Antagonists Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe CXCR4 Antagonists Revenue, 2017-2028
        6.4.2 Germany CXCR4 Antagonists Market Size, 2017-2028
        6.4.3 France CXCR4 Antagonists Market Size, 2017-2028
        6.4.4 U.K. CXCR4 Antagonists Market Size, 2017-2028
        6.4.5 Italy CXCR4 Antagonists Market Size, 2017-2028
        6.4.6 Russia CXCR4 Antagonists Market Size, 2017-2028
        6.4.7 Nordic Countries CXCR4 Antagonists Market Size, 2017-2028
        6.4.8 Benelux CXCR4 Antagonists Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia CXCR4 Antagonists Revenue, 2017-2028
        6.5.2 China CXCR4 Antagonists Market Size, 2017-2028
        6.5.3 Japan CXCR4 Antagonists Market Size, 2017-2028
        6.5.4 South Korea CXCR4 Antagonists Market Size, 2017-2028
        6.5.5 Southeast Asia CXCR4 Antagonists Market Size, 2017-2028
        6.5.6 India CXCR4 Antagonists Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America CXCR4 Antagonists Revenue, 2017-2028
        6.6.2 Brazil CXCR4 Antagonists Market Size, 2017-2028
        6.6.3 Argentina CXCR4 Antagonists Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa CXCR4 Antagonists Revenue, 2017-2028
        6.7.2 Turkey CXCR4 Antagonists Market Size, 2017-2028
        6.7.3 Israel CXCR4 Antagonists Market Size, 2017-2028
        6.7.4 Saudi Arabia CXCR4 Antagonists Market Size, 2017-2028
        6.7.5 UAE CXCR4 Antagonists Market Size, 2017-2028
7 Players Profiles
    7.1 Sanofi
        7.1.1 Sanofi Corporate Summary
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi CXCR4 Antagonists Major Product Offerings
        7.1.4 Sanofi CXCR4 Antagonists Revenue in Global Market (2017-2022)
        7.1.5 Sanofi Key News
    7.2 BioLineRx
        7.2.1 BioLineRx Corporate Summary
        7.2.2 BioLineRx Business Overview
        7.2.3 BioLineRx CXCR4 Antagonists Major Product Offerings
        7.2.4 BioLineRx CXCR4 Antagonists Revenue in Global Market (2017-2022)
        7.2.5 BioLineRx Key News
    7.3 X4 Pharmaceuticals
        7.3.1 X4 Pharmaceuticals Corporate Summary
        7.3.2 X4 Pharmaceuticals Business Overview
        7.3.3 X4 Pharmaceuticals CXCR4 Antagonists Major Product Offerings
        7.3.4 X4 Pharmaceuticals CXCR4 Antagonists Revenue in Global Market (2017-2022)
        7.3.5 X4 Pharmaceuticals Key News
    7.4 Eli Lilly
        7.4.1 Eli Lilly Corporate Summary
        7.4.2 Eli Lilly Business Overview
        7.4.3 Eli Lilly CXCR4 Antagonists Major Product Offerings
        7.4.4 Eli Lilly CXCR4 Antagonists Revenue in Global Market (2017-2022)
        7.4.5 Eli Lilly Key News
    7.5 Roche
        7.5.1 Roche Corporate Summary
        7.5.2 Roche Business Overview
        7.5.3 Roche CXCR4 Antagonists Major Product Offerings
        7.5.4 Roche CXCR4 Antagonists Revenue in Global Market (2017-2022)
        7.5.5 Roche Key News
    7.6 Merck
        7.6.1 Merck Corporate Summary
        7.6.2 Merck Business Overview
        7.6.3 Merck CXCR4 Antagonists Major Product Offerings
        7.6.4 Merck CXCR4 Antagonists Revenue in Global Market (2017-2022)
        7.6.5 Merck Key News
    7.7 Biokine Therapeutics
        7.7.1 Biokine Therapeutics Corporate Summary
        7.7.2 Biokine Therapeutics Business Overview
        7.7.3 Biokine Therapeutics CXCR4 Antagonists Major Product Offerings
        7.7.4 Biokine Therapeutics CXCR4 Antagonists Revenue in Global Market (2017-2022)
        7.7.5 Biokine Therapeutics Key News
    7.8 GlycoMimetics
        7.8.1 GlycoMimetics Corporate Summary
        7.8.2 GlycoMimetics Business Overview
        7.8.3 GlycoMimetics CXCR4 Antagonists Major Product Offerings
        7.8.4 GlycoMimetics CXCR4 Antagonists Revenue in Global Market (2017-2022)
        7.8.5 GlycoMimetics Key News
    7.9 Harmonic Pharma
        7.9.1 Harmonic Pharma Corporate Summary
        7.9.2 Harmonic Pharma Business Overview
        7.9.3 Harmonic Pharma CXCR4 Antagonists Major Product Offerings
        7.9.4 Harmonic Pharma CXCR4 Antagonists Revenue in Global Market (2017-2022)
        7.9.5 Harmonic Pharma Key News
    7.10 Upsher-Smith Laboratories
        7.10.1 Upsher-Smith Laboratories Corporate Summary
        7.10.2 Upsher-Smith Laboratories Business Overview
        7.10.3 Upsher-Smith Laboratories CXCR4 Antagonists Major Product Offerings
        7.10.4 Upsher-Smith Laboratories CXCR4 Antagonists Revenue in Global Market (2017-2022)
        7.10.5 Upsher-Smith Laboratories Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. CXCR4 Antagonists Market Opportunities & Trends in Global Market
    Table 2. CXCR4 Antagonists Market Drivers in Global Market
    Table 3. CXCR4 Antagonists Market Restraints in Global Market
    Table 4. Key Players of CXCR4 Antagonists in Global Market
    Table 5. Top CXCR4 Antagonists Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global CXCR4 Antagonists Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global CXCR4 Antagonists Revenue Share by Companies, 2017-2022
    Table 8. Global Companies CXCR4 Antagonists Product Type
    Table 9. List of Global Tier 1 CXCR4 Antagonists Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 CXCR4 Antagonists Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global CXCR4 Antagonists Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - CXCR4 Antagonists Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - CXCR4 Antagonists Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global CXCR4 Antagonists Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - CXCR4 Antagonists Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - CXCR4 Antagonists Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global CXCR4 Antagonists Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global CXCR4 Antagonists Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global CXCR4 Antagonists Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America CXCR4 Antagonists Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America CXCR4 Antagonists Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe CXCR4 Antagonists Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe CXCR4 Antagonists Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia CXCR4 Antagonists Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia CXCR4 Antagonists Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America CXCR4 Antagonists Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America CXCR4 Antagonists Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa CXCR4 Antagonists Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa CXCR4 Antagonists Revenue, (US$, Mn), 2023-2028
    Table 30. Sanofi Corporate Summary
    Table 31. Sanofi CXCR4 Antagonists Product Offerings
    Table 32. Sanofi CXCR4 Antagonists Revenue (US$, Mn), (2017-2022)
    Table 33. BioLineRx Corporate Summary
    Table 34. BioLineRx CXCR4 Antagonists Product Offerings
    Table 35. BioLineRx CXCR4 Antagonists Revenue (US$, Mn), (2017-2022)
    Table 36. X4 Pharmaceuticals Corporate Summary
    Table 37. X4 Pharmaceuticals CXCR4 Antagonists Product Offerings
    Table 38. X4 Pharmaceuticals CXCR4 Antagonists Revenue (US$, Mn), (2017-2022)
    Table 39. Eli Lilly Corporate Summary
    Table 40. Eli Lilly CXCR4 Antagonists Product Offerings
    Table 41. Eli Lilly CXCR4 Antagonists Revenue (US$, Mn), (2017-2022)
    Table 42. Roche Corporate Summary
    Table 43. Roche CXCR4 Antagonists Product Offerings
    Table 44. Roche CXCR4 Antagonists Revenue (US$, Mn), (2017-2022)
    Table 45. Merck Corporate Summary
    Table 46. Merck CXCR4 Antagonists Product Offerings
    Table 47. Merck CXCR4 Antagonists Revenue (US$, Mn), (2017-2022)
    Table 48. Biokine Therapeutics Corporate Summary
    Table 49. Biokine Therapeutics CXCR4 Antagonists Product Offerings
    Table 50. Biokine Therapeutics CXCR4 Antagonists Revenue (US$, Mn), (2017-2022)
    Table 51. GlycoMimetics Corporate Summary
    Table 52. GlycoMimetics CXCR4 Antagonists Product Offerings
    Table 53. GlycoMimetics CXCR4 Antagonists Revenue (US$, Mn), (2017-2022)
    Table 54. Harmonic Pharma Corporate Summary
    Table 55. Harmonic Pharma CXCR4 Antagonists Product Offerings
    Table 56. Harmonic Pharma CXCR4 Antagonists Revenue (US$, Mn), (2017-2022)
    Table 57. Upsher-Smith Laboratories Corporate Summary
    Table 58. Upsher-Smith Laboratories CXCR4 Antagonists Product Offerings
    Table 59. Upsher-Smith Laboratories CXCR4 Antagonists Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. CXCR4 Antagonists Segment by Type in 2021
    Figure 2. CXCR4 Antagonists Segment by Application in 2021
    Figure 3. Global CXCR4 Antagonists Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global CXCR4 Antagonists Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global CXCR4 Antagonists Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by CXCR4 Antagonists Revenue in 2021
    Figure 8. By Type - Global CXCR4 Antagonists Revenue Market Share, 2017-2028
    Figure 9. By Application - Global CXCR4 Antagonists Revenue Market Share, 2017-2028
    Figure 10. By Region - Global CXCR4 Antagonists Revenue Market Share, 2017-2028
    Figure 11. By Country - North America CXCR4 Antagonists Revenue Market Share, 2017-2028
    Figure 12. US CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe CXCR4 Antagonists Revenue Market Share, 2017-2028
    Figure 16. Germany CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 17. France CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia CXCR4 Antagonists Revenue Market Share, 2017-2028
    Figure 24. China CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 28. India CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America CXCR4 Antagonists Revenue Market Share, 2017-2028
    Figure 30. Brazil CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa CXCR4 Antagonists Revenue Market Share, 2017-2028
    Figure 33. Turkey CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE CXCR4 Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 37. Sanofi CXCR4 Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. BioLineRx CXCR4 Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. X4 Pharmaceuticals CXCR4 Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Eli Lilly CXCR4 Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Roche CXCR4 Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Merck CXCR4 Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Biokine Therapeutics CXCR4 Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. GlycoMimetics CXCR4 Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Harmonic Pharma CXCR4 Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Upsher-Smith Laboratories CXCR4 Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
63
Frequently Asked Questions
CXCR4 Antagonists Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CXCR4 Antagonists Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CXCR4 Antagonists Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Corn Headers Market

Corn Header is a joint machine that capable of complete reaping in corn harvesting. It allows the ... Read More